ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd (ADXN) Institutional Ownership
What the institutions did with ADXN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Only 5 managers reported a position this quarter, so the percentages above describe a very small sample.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| UBS Group AG | 47 | 97.9% |
| SBI Securities Co., Ltd. | 1 | 2.1% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| MORGAN STANLEY | Sold Out | 301 | 0 | -301 |
| GAMMA Investing LLC | Sold Out | 81 | 0 | -81 |
| RHUMBLINE ADVISERS | Sold Out | 72 | 0 | -72 |
| UBS Group AG | New | 0 | 47 | +47 |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.